326
Participants
Start Date
April 25, 2024
Primary Completion Date
May 25, 2027
Study Completion Date
May 25, 2027
Amoxicillin
"Participants will be randomized to IV/oral amoxicillin or IV/oral amoxicillin/clavulanate for 5 days. Both agents are approved for treatment of respiratory infections.~Amoxicillin PO: The dose is two capsule of 500 mg every 8 hours (that is 3 times daily).~Amoxicillin IV: The dose is 1 g every 8 hours (that is 3 times daily)"
Amoxicillin/clavulanate
"Participants will be randomized to IV/oral amoxicillin or IV/oral amoxicillin/clavulanate for 5 days. Both agents are approved for treatment of respiratory infections.~Amoxicillin/clavulanate PO: The dose is two tablets of 500 mg/62.5 mg every 8 hours (that is 3 times daily, approved standard dose) Amoxicillin/clavulanate IV: The dose is 1 g/200 mg every 8 hours (that is 3 times daily, approved standard dose)"
RECRUITING
Chu Angers, Angers
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Avicenne AP-HP, Bobigny
RECRUITING
CHU Avicenne AP-HP, Bobigny
RECRUITING
CHRU Brest, Brest
RECRUITING
CHRU Brest, Brest
RECRUITING
CHD Vendée, La Roche-sur-Yon
RECRUITING
CHD Vendée, La Roche-sur-Yon
RECRUITING
CHU Grenoble-Alpes, La Tronche
RECRUITING
CHU Grenoble-Alpes, La Tronche
RECRUITING
Assistance Publique Hopitaux De Marseille, Marseille
RECRUITING
CHU de Nantes, Nantes
RECRUITING
CH Perigueux, Périgueux
RECRUITING
CHRU - TOULOUSE Hôpital Purpan, Toulouse
RECRUITING
CHRU - TOULOUSE Hôpital Purpan, Toulouse
RECRUITING
CHRU TOULOUSE - Hôpital Rangueuil, Toulouse
RECRUITING
Centre Hospitalier Bretagne Atlantique, Vannes
Nantes University Hospital
OTHER